One is a drug used to treat rheumatoid arthritis while the other is a monoclonal antibody therapy created to tackle the novel coronavirus. It had said then that it had received permission for restricted emergency use from Central Drugs Standard Control Organisation “for baricitinib in combination with remdesivir, for treatment of suspected or laboratory confirmed Covid-19 in hospitalised adults requiring …
